Direct conversion to neural stem cells de-ages human blood cells

Converted cells preserved around 13% and 5% of original donor age at low and high passages, respectively, through a protracted de-aging process.

Aging Cell

In human blood cells from donors ranging from neonatal to 101 years of age, researchers tracked cellular rejuvenation during direct lineage conversion into induced neural stem cells. The team overexpressed the reprogramming factors SOX2 and cMYC in erythroid progenitors to generate neural stem cells without passing through an intermediate pluripotent state.

An epigenetic clock algorithm revealed that the direct conversion drove pronounced epigenetic de-aging. This rejuvenation was protracted, continuing over several weeks and persisting even under proliferation-inhibiting conditions. Transcriptomic differences between cells from young and old donors dissipated with extended conversion time, and established lines lacked age-associated cellular hallmarks. Additionally, time-course profiling of DNA methylation and RNA sequencing revealed that gaining a bona fide neural stem cell signature continued well after proliferative, PAX6-positive cells first emerged.

Why it matters

Determining how direct lineage conversion erases epigenetic age without an intermediate pluripotent state helps uncover the distinct cellular mechanisms driving rejuvenation.

Caveats

The findings are derived entirely from in vitro human cell cultures and describe cellular reprogramming rather than in vivo tissue rejuvenation.

The paper

Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells

Lea Jessica Berg, Julia Franzen, Andreas Buness,
Show 5 more authorsRachel Konang, Chao Sheng, Michael Peitz, Andreas Till, Wolfgang Wagner,
Oliver Brüstle

University of Bonn Medical Faculty & University Hospital Bonn

Aging Cell · 1 Oct 2026

doi.org/10.1111/acel.70751PubMed 42829448